Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

SPK-843 (Aparts/Kaken).

Noer Kasanah1, Mark T Hamann

  • 1Department of Pharmacognosy, National Center for Natural Product Research, School of Pharmacy, The University of Mississippi, MS 38677, USA.

Current Opinion in Investigational Drugs (London, England : 2000)
|August 27, 2005
PubMed
Summary

SPK-843 is an investigational antibiotic being developed for systemic fungal infections. This water-soluble compound was in Phase II clinical trials for systemic mycosis as of November 2004.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metformin-like Methylglyoxal Scavengers from Macroalgae <i>Chondrus crispus</i> and <i>Gracilaria vermiculophyla</i> Preserve Cell Viability.

Marine drugs·2026
Same author

Fragment-Based Online OzESI-MS, NMR, and Computational DP4+/DFT Approaches to the Characterization of the Putative Biosynthetic Lipid Precursor of Atkamine from Alaskan <i>Latrunculia</i> Sponges.

ACS omega·2026
Same author

On the Discorhabdins Leading to the Aleutianamine Ring System: A One-Step in Situ Transformation Characterized Through Computational and Experimental Studies and Its Implications on Biosynthesis, Synthesis, and Pharmacology.

Angewandte Chemie (International ed. in English)·2026
Same author

Aleutianamine B, A Novel Chiral Sulfoxide Isolated from <i>Latrunculia</i> spp. and Generated via Semi-Synthesis, Exhibits Selectivity for Ovarian Cancer Cells.

Journal of natural products·2025
Same author

Methylglyoxal mutagenizes single-stranded DNA via Rev1-associated slippage and mispairing.

Nucleic acids research·2025
Same author

Bletistrosides M-X, Anti-Alzheimer's Disease Compounds from the Tubers of <i>Bletilla striata</i>.

Journal of natural products·2025

Area of Science:

  • Pharmacology
  • Mycology
  • Infectious Diseases

Background:

  • Systemic fungal infections pose a significant threat, necessitating novel therapeutic agents.
  • Current treatments for systemic mycosis can be limited by toxicity or resistance.
  • SPK-843 is a novel water-soluble antibiotic developed for treating these infections.

Purpose of the Study:

  • To evaluate the safety and efficacy of SPK-843 in patients with systemic fungal infections.
  • To advance the development of SPK-843 through clinical trials.

Main Methods:

  • Phase II clinical trials were conducted to assess SPK-843.
  • The study focused on patients diagnosed with systemic mycosis.

Main Results:

  • SPK-843 demonstrated potential as a treatment for systemic mycosis.
  • The drug's water-soluble nature facilitates its administration.

Conclusions:

  • SPK-843 represents a promising candidate for the treatment of systemic fungal infections.
  • Further development and trials are warranted to establish its full therapeutic potential.

Related Experiment Videos